"Drs. Brett Miles and Marshall Posner - FDA Awards Grant for Phase 2 Study of Immunotherapy Drug used in HPV-Associated Head and Neck Cancer"

Mount Sinai Performs First-in-the-World Liver Cancer Treatment Using More Flexible Scheduling Approach

Mount Sinai Study Finds Lung Cancer Surgery Safe for Many Patients Over 80

Mount Sinai Study Identifies Inflammatory Immune Pathway Driving Immunotherapy Resistance in Bladder Cancer

Mount Sinai Study May Help Cancer Patients Keep Their Bladder

Mount Sinai Study Strengthens Landmark Evidence Supporting Lung-Sparing Surgery, Offering Hope for Mesothelioma Patients

Researchers Advance Understanding of Female Sexual Anatomy to Improve Pelvic Cancer Radiotherapy

Mount Sinai Review Maps the Path Forward for Cancer Vaccines, Highlighting Promise of Personalized and Combination Approaches

Exposure to “Forever Chemicals” Linked to Higher Risk of Gestational Diabetes, Major Review Finds

Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients

Mount Sinai Launches AI-Powered Clinical Trial-Matching Platform to Expand Access to Cancer Research

Icahn School of Medicine at Mount Sinai Named Member of the Milken Institute’s Women’s Health Network